LABNEW (LAB) 24-hour volatility at 39.1%: Whale accumulation and surge in trading volume drive rebound
Bitget Pulse2026/05/14 16:02Volatility Brief
LABNEW (LAB) saw its price rebound from a 24-hour low of $4.8022 to a high of $6.68182, currently trading at $5.46349, with a volatility amplitude reaching 39.1%. The 24-hour trading volume remained in the $55 to $73 million range, and on-chain data indicates a significant net capital inflow.
Analysis of Unusual Movements
- Whale Accumulation: On-chain monitoring shows several new wallets withdrew approximately 30% of the circulating supply from exchanges (around 100 million LAB, valued at over $500 million), with an average cost of about $4.90, setting the stage for the price increase.
- Trading Volume Surge: The 24-hour trading volume soared more than 7 times, driving the price to rebound over 32% from the low.
- Net Capital Inflow: On-chain data confirms a significant net capital inflow, supporting the short-term rebound.
Market Opinions and Outlook
Community sentiment leans towards caution, with whales clearly leading during this high volatility. Discussions on X platform point out that the price is ranging between $4.14 and $9.05, and waning momentum may trigger a 40-50% retracement; analysts highlight increasing manipulation signals and suggest focusing on the risk of 1-4 hour structural breakdowns.
Note: This analysis is automatically generated by AI based on publicly available data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nebius Q3 results exceed expectations, capital expenditure rises to $27 billion, ARR target postponed, stock falls over 14% pre-market | Earnings Report Insights
Nebius reported Q3 revenue of $981 million (a year-on-year increase of 571%) and adjusted EBITDA of $466 million, both exceeding expectations. However, the company delayed and lowered its guidance for annual recurring revenue (ARR), stating that it is no longer applicable. Additionally, it significantly raised its 2026 capital expenditure target to $27 billion, with projections to further increase to $40 billion to $45 billion in 2027. The stock price plummeted more than 14% in pre-market trading.